Innovation drug concept continues to be strong, Haixin shares hit 4 consecutive daily limit.

In the early morning session, the concept of innovative drugs continued to show strong performance, with Haixin Group hitting a 4-consecutive limit up, Hainan Haiyao up for 2 consecutive days, Canaan Technology rising more than 10%, and Jinfeng Medicine, Xinhua Pharmaceutical, and Leap Medical leading the gains.